Pharma Co. Exits Latest Investor Suit Over Liver Disease Drug
Intercept Pharmaceuticals Inc. has defeated a proposed securities class action accusing it of covering up reports of fatalities and injuries caused by a liver disease drug, after a New York federal...To view the full article, register now.
Already a subscriber? Click here to view full article